Search - Prime Therapeutics

388 Results for GLP-1 Pipeline Update

U.S. News & World Report: Only 1 in 4 Still Taking Ozempic, Wegovy for Weight Loss Two Years Later

U.S. News & World Report

PA Sub-Categories: GLP-1 Prime Article: In the News
Forbes: Study Shows 85% Of Patients Discontinue GLP-1s For Weight Loss After 2 Years

Forbes

PA Sub-Categories: GLP-1 Prime Article: In the News
Drug Approvals Monthly Update: March 2024

Read Drug Approvals Monthly Update: March 2024 Critical updates in an ever-changing environment Drug Approval Update Specialty New drugs 3/13/2024 Tevimbra™ (tislelizumab-jsgr) Tevimbra, a...
Clinical Highlights: November 2024

Publications Clinical Highlights: November 2024 Your monthly source for drug information highlights. November 27, 2024 Weight Management Corner: catch up on recent publications and study findings...